Abbott India Faces Mixed Technical Trends Amid Strong Historical Performance
2025-04-02 08:07:56Abbott India, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 30,245.10, showing a slight decline from the previous close of 30,560.15. Over the past year, Abbott India has demonstrated a robust performance with a return of 9.95%, significantly outperforming the Sensex, which returned 2.72% in the same period. The technical summary indicates a mixed outlook, with the MACD showing bullish signals on a weekly basis while presenting a mildly bearish stance monthly. The Bollinger Bands and moving averages suggest a mildly bullish trend, indicating some positive momentum in the short term. However, the KST reflects a similar divergence, being bullish weekly but mildly bearish monthly. In terms of stock performance relative to the Sensex, Abbott India has shown resilience, particularl...
Read More
Abbott India Shows Strong Market Position Amid Positive Sector Trends
2025-03-24 12:45:22Abbott India has demonstrated strong market activity, trading close to its 52-week high and outperforming the pharmaceuticals sector. The stock is above key moving averages, indicating positive momentum. Meanwhile, the broader market, represented by the Sensex, has also shown gains, particularly in mid-cap stocks.
Read More
Abbott India Shows Long-Term Resilience Amid Short-Term Volatility in Stock Performance
2025-03-12 12:20:20Abbott India Ltd. saw a decline on March 12, 2025, closing at Rs 29,775.35, underperforming against the broader market. Despite this, the stock has shown resilience, gaining 3.96% over the past month and 11.06% over the last year, while maintaining a strong long-term trajectory with significant growth over the past decade.
Read More
Abbott India Reaches 52-Week High Amid Broader Market Decline and Volatility
2025-03-04 10:26:40Abbott India has reached a new 52-week high of Rs. 31,900, despite a broader market decline. The stock experienced a slight dip after two days of gains but remains above key moving averages. Over the past year, it has outperformed the Sensex, reflecting its strong performance in the pharmaceuticals sector.
Read More
Abbott India Achieves All-Time High Amid Broader Market Challenges
2025-03-03 18:00:27Abbott India has reached a new all-time high, showing strong performance with consecutive gains over the past two days. The stock is trading above multiple moving averages, indicating a solid market position, while the broader Nifty index has faced recent challenges, reflecting contrasting trends in the market.
Read More
Abbott India Reaches New 52-Week High, Signaling Strong Market Resilience
2025-03-03 14:21:06Abbott India has reached a new 52-week high of Rs. 31,098.95, reflecting strong market performance. The stock has gained 3.44% over the past two days and is trading above all key moving averages. Over the past year, it has outperformed the Sensex, highlighting its resilience in the industry.
Read More
Abbott India Achieves 52-Week High Amid Strong Trading Activity and Sector Resilience
2025-02-28 15:35:25Abbott India has achieved a new 52-week high in its stock price, reflecting strong trading activity and outperforming its sector. The stock has shown resilience, trading above key moving averages and delivering a notable return over the past year, despite challenges in the broader Pharmaceuticals & Drugs sector.
Read More
Abbott India Shows Strong Market Momentum Amid Positive Sentiment Shift
2025-02-24 15:05:18Abbott India Ltd. has demonstrated strong market performance, gaining 3.04% on February 24, 2025, and outperforming its sector. The stock is close to its 52-week high and has reversed a two-day decline. It has also shown positive momentum, trading above key moving averages and gaining 9.40% over the past month.
Read More
Abbott India Demonstrates Strong Market Resilience Amid Broader Economic Trends
2025-02-18 15:05:20Abbott India Ltd. has demonstrated strong market performance, gaining 3.17% on February 18, 2025, and outperforming its sector. The stock has consistently risen over the past two days and is trading above key moving averages, indicating a robust trend amid broader market fluctuations.
Read MoreAnnouncement under Regulation 30 (LODR)-Change in Management
01-Apr-2025 | Source : BSEAppointment of Senior Management Personnel.
Announcement under Regulation 30 (LODR)-Change in Management
26-Mar-2025 | Source : BSEResignation of Senior Management Personnel of the Company
Closure of Trading Window
25-Mar-2025 | Source : BSEClosure of Trading Window
Corporate Actions
No Upcoming Board Meetings
Abbott India Ltd. has declared 4100% dividend, ex-date: 19 Jul 24
No Splits history available
No Bonus history available
No Rights history available